Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer. Pacltaxel is active in metastatic breast cancer, ...
A phase I study of clofarabine and liposomal daunorubicin in childhood and adolescent acute myeloid leukemia. Background: Both vinorelbine (VNR) and temozolomide (TMZ), as well as camptotecin ...